The R&D Premium and Takeover Risk

被引:20
|
作者
Lin, Ji-Chai [1 ]
Wang, Yanzhi [2 ]
机构
[1] Hong Kong Polytech Univ, Hong Kong, Hong Kong, Peoples R China
[2] Natl Taiwan Univ, Taipei, Taiwan
来源
ACCOUNTING REVIEW | 2016年 / 91卷 / 03期
关键词
R&D; takeover risk; risk premium; FINANCIAL CONSTRAINTS; CROSS-SECTION; DEVELOPMENT INVESTMENT; RETURNS; EFFICIENCY; EARNINGS;
D O I
10.2308/accr-51270
中图分类号
F8 [财政、金融];
学科分类号
0202 ;
摘要
To explain why firms with high research and development (R&D) intensity offer their investors higher stock returns, we argue that (1) high R&D capacity relative to firm valuation makes R&D-intensive firms attractive takeover targets, and that (2) the higher takeover probability leads their investors to face higher takeover risk, as proposed by Cremers, Nair, and John (2009), and require higher returns. We find evidence consistent with our hypothesis. Furthermore, we find that takeover probability also relates to large R&D increases, but not to innovation efficiency. Accordingly, we expect and find that takeover risk helps to explain the premium associated with large R&D increases, but not the innovation efficiency premium previously documented.
引用
收藏
页码:955 / 971
页数:17
相关论文
共 50 条
  • [1] R&D and the patent premium
    Arora, Ashish
    Ceccagnoli, Marco
    Cohen, Wesley M.
    INTERNATIONAL JOURNAL OF INDUSTRIAL ORGANIZATION, 2008, 26 (05) : 1153 - 1179
  • [2] R&D Premium: The Intangible Side of Value
    Cai, Li
    Cooper, Ricky
    He, Di
    JOURNAL OF INVESTING, 2023, 32 (06): : 61 - 76
  • [3] R&D goal seeking and risk taking in biotechnology R&D investments
    Ng, Desmond
    INTERNATIONAL FOOD AND AGRIBUSINESS MANAGEMENT REVIEW, 2023, 26 (03): : 555 - 575
  • [4] Another cluster premium: Innovation subsidies and R&D collaboration networks
    Broekel, Tom
    Fornahl, Dirk
    Morrison, Andrea
    RESEARCH POLICY, 2015, 44 (08) : 1431 - 1444
  • [5] Risk and uncertainty in R&D management
    Moehrle, Martin G.
    Walter, Lothar
    R & D MANAGEMENT, 2008, 38 (05) : 449 - 451
  • [6] The R&D anomaly: Risk or mispricing?
    Leung, Woon Sau
    Evans, Kevin R.
    Mazouz, Khelifa
    JOURNAL OF BANKING & FINANCE, 2020, 115
  • [7] MANAGING RISK IN PHARMACEUTICAL R&D
    Case, Randolph H.
    RESEARCH-TECHNOLOGY MANAGEMENT, 2010, 53 (02) : 24 - 32
  • [8] Risk taking in R&D organizations
    Smith, MJ
    CHEMICAL INNOVATION, 2000, 30 (06): : 15 - 20
  • [9] R&D investment and distress risk
    Zhang, Wei
    JOURNAL OF EMPIRICAL FINANCE, 2015, 32 : 94 - 114
  • [10] Risk management in R&D projects
    Kasap, Deniz
    Asyali, Istemi Sidre
    Elci, Kemal
    PICMET '07: PORTLAND INTERNATIONAL CENTER FOR MANAGEMENT OF ENGINEERING AND TECHNOLOGY, VOLS 1-6, PROCEEDINGS: MANAGEMENT OF CONVERGING TECHNOLOGIES, 2007, : 2287 - +